021-51111890
购物车（）
sales@molnova.cn
Tomeglovir
CAS No. 233254-24-5
Tomeglovir ( BAY 38-4766;BAY 384766 )
产品货号. M13667 CAS No. 233254-24-5
Tomeglovir (BAY 384766) is a potent, highly selective, nonnucleoside inhibitor of cytomegalovirus (CMV) replication.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 100MG | 获取报价 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Tomeglovir
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Tomeglovir (BAY 384766) is a potent, highly selective, nonnucleoside inhibitor of cytomegalovirus (CMV) replication.
-
产品描述Tomeglovir (BAY 384766) is a potent, highly selective, nonnucleoside inhibitor of cytomegalovirus (CMV) replication; selectively inhibits not only HCMV strains, including ganciclovir-resistant clinical isolates, but also a number of monkey and rodent cytomegaloviruses.CMV Infection Phase 2 Discontinued
-
同义词BAY 38-4766;BAY 384766
-
通路Microbiology/Virology
-
靶点CMV
-
受体CMV
-
研究领域Infection
-
适应症CMV Infection
化学信息
-
CAS Number233254-24-5
-
分子量441.55
-
分子式C23H27N3O4S
-
纯度>98% (HPLC)
-
溶解度DMSO : ≥ 108 mg/mL 244.60 mM
-
SMILESO=C(NC1=CC=C(NS(=O)(C2=C3C=CC=C(N(C)C)C3=CC=C2)=O)C=C1)C(C)(C)CO
-
化学全称N-(4-(((5-(Dimethylamino)-1-naphthyl)sulfonyl)amino)phenyl)-3-hydroxy-2,2-dimethylpropionamide
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Weber O, et al. Antiviral Res. 2001 Mar;49(3):179-89.
2. Buerger I, et al. J Virol. 2001 Oct;75(19):9077-86.
3. Reefschlaeger J, et al. J Antimicrob Chemother. 2001 Dec;48(6):757-67.
2. Buerger I, et al. J Virol. 2001 Oct;75(19):9077-86.
3. Reefschlaeger J, et al. J Antimicrob Chemother. 2001 Dec;48(6):757-67.
产品手册
关联产品
-
Cidofovir
The prodrug of cidofovir diphosphate that inhibits cytomegalovirus (CMV) viral replication by selectively inhibiting viral DNA polymerases.
-
GW 275175X
GW 275175X is a derivative of BDCRB that displays anti-HCMV activity by inhibition of viral DNA maturation.
-
Cidofovir dihydrate
The prodrug of cidofovir diphosphate that inhibits cytomegalovirus (CMV) viral replication by selectively inhibiting viral DNA polymerases.
